Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$47.46 USD
-0.03 (-0.06%)
Updated May 3, 2024 04:00 PM ET
After-Market: $47.43 -0.03 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/7/24 |
---|---|
Current Quarter | -0.54 |
EPS Last Quarter | -0.73 |
Last EPS Surprise | -10.61% |
ABR | 1.44 |
Earnings ESP
|
2.22% |
---|---|
Current Year | -1.27 |
Next Year | 1.04 |
EPS (TTM) | -4.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 160.51M | 190.09M | 798.97M | 1.16B |
# of Estimates | 8 | 8 | 8 | 7 |
High Estimate | 198.15M | 255.31M | 1.03B | 1.28B |
Low Estimate | 137.45M | 171.13M | 719.23M | 1.04B |
Year ago Sales | 44.85M | 94.97M | 396.59M | 798.97M |
Year over Year Growth Est. | 257.88% | 100.16% | 101.46% | 45.44% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.54 | -0.37 | -1.27 | 1.04 |
# of Estimates | 10 | 8 | 10 | 9 |
Most Recent Consensus | -0.14 | 0.26 | 1.14 | 2.47 |
High Estimate | -0.14 | 0.26 | 1.14 | 2.47 |
Low Estimate | -0.83 | -0.60 | -2.18 | 0.07 |
Year ago EPS | -1.56 | -1.02 | -4.45 | -1.27 |
Year over Year Growth Est. | 65.38% | 63.73% | 71.46% | 182.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 3 | 2 | 3 | 1 |
Up Last 60 Days | 4 | 3 | 4 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 1 | 1 | 4 |
Down Last 60 Days | 3 | 2 | 2 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.54 | -0.37 | -1.27 | 1.04 |
7 Days Ago | -0.55 | -0.39 | -1.34 | 1.02 |
30 Days Ago | -0.53 | -0.39 | -1.36 | 1.04 |
60 Days Ago | -0.53 | -0.37 | -1.27 | 1.14 |
90 Days Ago | -0.53 | -0.38 | -1.32 | 0.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.53 | -0.13 | -0.83 | 1.47 |
Zacks Consensus Estimate | -0.54 | -0.37 | -1.27 | 1.04 |
Earnings ESP | 2.22% | 64.09% | 35.19% | 41.11% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.73 | -1.17 | -1.02 | -1.56 | NA |
Estimate | -0.66 | -0.84 | -1.35 | -1.42 | NA |
Difference | -0.07 | -0.33 | 0.33 | -0.14 | -0.05 |
Surprise | -10.61% | -39.29% | 24.44% | -9.86% | -8.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more